CV Therapeutics extends poison pill for another year(0)
The board of directors at CV Therapeutics decided to extend by a year the shareholders rights plan they have in place to fend off hostile takeovers. The plan, otherwise known as a poison pill, was set to expire Read the rest of this entry »
Subscribe via RSS all feeds